A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205
Clinical trial NCT04241068 · TERMINATED
Trial details
- NCT number
- NCT04241068
- Sponsor
- Biogen
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-02
- Primary completion
- 2024-07-22
- Enrollment
- 1696
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.